Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- allogeneic processed thymus tissue
Interactions between your drugs
allogeneic processed thymus tissue RSV vaccine, preF A-preF B, recombinant
Applies to: allogeneic processed thymus tissue, Abrysvo (rsv vaccine, pref a-pref b, recombinant)
Patients that have been treated with allogeneic processed thymus tissue should let their doctor know before receiving RSV vaccine, preF A-preF B, recombinant. Allogeneic processed thymus tissue is intended to help the body develop a part of the immune system called T cells, which are important to help the body fight infections and can help vaccines work to protect the body against certain diseases. Depending on the length of time since they have been treated with allogeneic processed thymus tissue, their body may not have had enough time to develop this part of the immune system, which may lead to a reduced response to RSV vaccine, preF A-preF B, recombinant. In some situations, their doctor may want to delay vaccination with RSV vaccine, preF A-preF B, recombinant until the patient's immune system is improved. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Rsv vaccine pref3, recombinant
Rsv vaccine pref3, recombinant is used for RSV, RSV Vaccination and Immunization
Palivizumab
Palivizumab is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.